search
Back to results

Effects of Folic Acid Supplementation on Arsenic Lowering

Primary Purpose

Arsenic Poisoning, Toxic Effect of Arsenic and Its Compounds

Status
Unknown status
Phase
Phase 2
Locations
Study Type
Interventional
Intervention
folic acid supplementation
Sponsored by
Wenzhou Medical University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Arsenic Poisoning focused on measuring arsenic induced health problem, modifying effects, folic acid, oxidative damage, clinical trial

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Men or women more than 18 years of age and chronically exposed to arsenic (arsenic concentration of the drinking water >10ug/L);
  • Population who had no folic acid supplementation in the 2 weeks before the study;
  • Women of childbearing age agreed to use a reliable contraception method during the study;
  • Everyone volunteered to participate and signed informed consent.

Exclusion Criteria:

  • Pregnant or breast-feeding women;
  • Allergic to folic acid;
  • Having clearly defined allergic history;
  • Reported long-term use of folic acid and other vitamins B;
  • Having obvious signs or laboratory abnormalities which could affect the efficacy of folic acid;
  • Unsuitable to participate in the study based on the judgment of the investigators;
  • Not agree to cancel the medications which may affect serum folate concentration during the study period;
  • Subjects who plan to become pregnant during the study or move out of the area within the study period;

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    folic acid

    Arm Description

    folic acid supplementation placebo controlled

    Outcomes

    Primary Outcome Measures

    Change of urine arsenic metabolites between baseline and week 8

    Secondary Outcome Measures

    Full Information

    First Posted
    August 28, 2014
    Last Updated
    September 9, 2014
    Sponsor
    Wenzhou Medical University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02235948
    Brief Title
    Effects of Folic Acid Supplementation on Arsenic Lowering
    Official Title
    Efficacy and Safety of Folic Acid Supplementation Lowering Arsenic in a Chronic, Low-level Exposed Arsenic Population: a Randomized, Double-blind, Placebo Controlled Clinical Trial.
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    September 2014
    Overall Recruitment Status
    Unknown status
    Study Start Date
    July 2014 (undefined)
    Primary Completion Date
    July 2015 (Anticipated)
    Study Completion Date
    December 2016 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Wenzhou Medical University

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    The purpose of this study is to determine whether folic acid supplementation are effective on arsenic lowering in a chronic, low-level arsenic exposed population.
    Detailed Description
    Outcome measure: Changes of arsenic metabolites at baseline and week 8 Methods High-performance liquid chromatography (HPLC)

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Arsenic Poisoning, Toxic Effect of Arsenic and Its Compounds
    Keywords
    arsenic induced health problem, modifying effects, folic acid, oxidative damage, clinical trial

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Phase 2
    Interventional Study Model
    Single Group Assignment
    Masking
    ParticipantInvestigator
    Allocation
    N/A
    Enrollment
    450 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    folic acid
    Arm Type
    Experimental
    Arm Description
    folic acid supplementation placebo controlled
    Intervention Type
    Drug
    Intervention Name(s)
    folic acid supplementation
    Other Intervention Name(s)
    placebo controlled
    Intervention Description
    0.8mg folic acid/day
    Primary Outcome Measure Information:
    Title
    Change of urine arsenic metabolites between baseline and week 8
    Time Frame
    baseline, week 8

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Men or women more than 18 years of age and chronically exposed to arsenic (arsenic concentration of the drinking water >10ug/L); Population who had no folic acid supplementation in the 2 weeks before the study; Women of childbearing age agreed to use a reliable contraception method during the study; Everyone volunteered to participate and signed informed consent. Exclusion Criteria: Pregnant or breast-feeding women; Allergic to folic acid; Having clearly defined allergic history; Reported long-term use of folic acid and other vitamins B; Having obvious signs or laboratory abnormalities which could affect the efficacy of folic acid; Unsuitable to participate in the study based on the judgment of the investigators; Not agree to cancel the medications which may affect serum folate concentration during the study period; Subjects who plan to become pregnant during the study or move out of the area within the study period;
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Xiao Xiao, MD, PhD
    Organizational Affiliation
    Wenzhou Medical University
    Official's Role
    Study Director

    12. IPD Sharing Statement

    Citations:
    PubMed Identifier
    34661903
    Citation
    Bae S, Kamynina E, Guetterman HM, Farinola AF, Caudill MA, Berry RJ, Cassano PA, Stover PJ. Provision of folic acid for reducing arsenic toxicity in arsenic-exposed children and adults. Cochrane Database Syst Rev. 2021 Oct 18;10(10):CD012649. doi: 10.1002/14651858.CD012649.pub2.
    Results Reference
    derived
    PubMed Identifier
    31666259
    Citation
    Wei Y, Jia C, Lan Y, Hou X, Zuo J, Li J, Wang T, Mao G. The association of tryptophan and phenylalanine are associated with arsenic-induced skin lesions in a Chinese population chronically exposed to arsenic via drinking water: a case-control study. BMJ Open. 2019 Oct 30;9(10):e025336. doi: 10.1136/bmjopen-2018-025336.
    Results Reference
    derived
    PubMed Identifier
    26559255
    Citation
    Guo X, Cui H, Zhang H, Guan X, Zhang Z, Jia C, Wu J, Yang H, Qiu W, Zhang C, Yang Z, Chen Z, Mao G. Protective Effect of Folic Acid on Oxidative DNA Damage: A Randomized, Double-Blind, and Placebo Controlled Clinical Trial. Medicine (Baltimore). 2015 Nov;94(45):e1872. doi: 10.1097/MD.0000000000001872.
    Results Reference
    derived

    Learn more about this trial

    Effects of Folic Acid Supplementation on Arsenic Lowering

    We'll reach out to this number within 24 hrs